News Novartis AG Nyse

Equities

NVS

US66987V1098

Market Closed - Nyse Other stock markets 21:00:01 07/05/2024 BST			5-day change	1st Jan Change
99.07 ^USD	+1.37%		+2.00%	-1.88%

05-06	NOVARTIS AG : UBS maintains a Buy rating	ZD
05-02	Health Care Flat Amid Mixed Earnings -- Health Care Roundup	DJ

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NOVARTIS AG : UBS maintains a Buy rating	05-06	ZD
Health Care Flat Amid Mixed Earnings -- Health Care Roundup	05-02	DJ
Sector Update: Health Care Stocks Softer Late Afternoon	05-02	MT
Sector Update: Health Care Stocks Retreat Thursday Afternoon	05-02	MT
Top Midday Stories: Novo Nordisk, Linde Shares Fall Post-Earnings; Peloton Shares Plummet After Announcing Job Cuts, CEO Change; Exxon-Pioneer Deal Gets FTC Approval With One Caveat	05-02	MT
News Highlights : Top Company News of the Day - Thursday at 11 AM ET	05-02	DJ
Novartis AG to Acquire Mariana Oncology in Deal Valued Up to $1.75 Billion.	05-02	MT
News Highlights : Top Company News of the Day - Thursday at 9 AM ET	05-02	DJ
Novartis : enters agreement to acquire Mariana Oncology, strengthening radioligand therapy pipeline	05-02	PU
Novartis: acquisition of US-based Mariana Oncology	05-02	CF
Switzerland's Novartis to Buy US-based Mariana Oncology for $1 Billion Upfront	05-02	MT
Novartis to Buy Mariana Oncology, Pay $1 Billion Upfront	05-02	MT
Novartis AG to Acquire Mariana Oncology	05-02	MT
Novartis AG to Acquire Mariana Oncology	05-02	MT
Novartis to Buy Mariana Oncology for Up to $1.75 Billion in Boost to Radioligand Therapy Business	05-02	DJ
Novartis to buy radiology specialist Mariana Oncology for $1 billion	05-02	RE
Chimeric Therapeutics Appoints COO; Shares Rise 4%	05-02	MT
Novartis AG entered into an agreement to acquire Mariana Oncology, Inc. from Atlas Venture L.P., Access Biotechnology, RA Capital Management, L.P., Deep Track Capital, LP, Forbion Capital Partners B.V. and others for $1.8 billion.	05-01	CI
Avacta picks Christina Coughlin to replace long-serving CEO	05-01	AN
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications	04-30	MT